Specifically, Chugai has filed for regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for FoundationOne CDx™, which, if approved in Japan, would enable access to ...
Illumina is expanding access to its oncology range of in vitro diagnostic (IVD) tests, as the company's TruSight Oncology (TSO) Comprehensive IVD is now covered under Medicare. This coverage also ...
MELBOURNE, Australia and INDIANAPOLIS, Dec. 11, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a United ...
SUFFERN, NEW YORK / ACCESS Newswire / July 24, 2025 / CDx Diagnostics announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for its proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback